Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05325970 · ClinicalTrials.gov registry record
Clinical Registry of Long-Term Dental Outcomes in Head and Neck Cancer Patients
A clinical trial of Head and Neck Cancer and Dental Diseases, sponsored by Wake Forest University Health Sciences.
- Active
- Registry status
- 350
- Enrollment target
- 6
- Study locations
NCT05325970 is a study of Head and Neck Cancer and Dental Diseases that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 350 participants, above the 259-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (35% higher). The trial reports 6 study locations across 6 states.
The verdict
NCT05325970, a study of Head and Neck Cancer and Dental Diseases, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- 350 participants
- Enrollment target
- 6
- Study locations
Study Summary
The current study (ORARAD II) will examine participants of the original cohort for a visit roughly 7 years after the start of RT. The primary outcomes will be the 7-year rate of dental caries, periodontal disease, tooth loss, osteoradionecrosis and salivary flow.
Conditions Studied
Study Locations (6)
Connecticut
- University of Connecticut Health Center - School of Dental Medicine - Farmington
Massachusetts
- Brigham and Women's Hospital - Boston
Minnesota
- University of Minnesota - Minneapolis
New York
- New York University - College of Dentistry - New York
North Carolina
- University of North Carolina School of Dentistry - Chapel Hill
Pennsylvania
- University of Pennsylvania School of Dental Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2014-02 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05325970
The ClinicalTrials.gov registry entry for NCT05325970 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 259-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (35% higher). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT05325970 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Connecticut, Massachusetts, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05325970 about?
NCT05325970 is a clinical study titled "Clinical Registry of Long-Term Dental Outcomes in Head and Neck Cancer Patients". The current study (ORARAD II) will examine participants of the original cohort for a visit roughly 7 years after the start of RT. The primary outcomes will be the 7-year rate of dental caries, periodontal disease, tooth loss, osteoradionecrosis and salivary flow.
What is the current status of trial NCT05325970?
This trial is currently active not recruiting. The enrollment target is 350 participants. The study started on 2014-02. Estimated completion is 2026-06.
What conditions does trial NCT05325970 study?
This clinical trial studies the following conditions: Head and Neck Cancer, Dental Diseases, Osteoradionecrosis.
Who is sponsoring clinical trial NCT05325970?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05325970 being conducted?
This trial has 6 study locations across Connecticut, Massachusetts, Minnesota, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
3D Specimen Maps for RT Planning
RECRUITING
-
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
RECRUITING · Phase 1
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
RECRUITING · NA
-
RAPA-201 Therapy of Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.